Get started
Author

Doortje I Krijbolder

Observed names: D. Krijbolder, D.I. Krijbolder, Doortje I. Krijbolder, Doortje Isabelle Krijbolder, Doortje Krijbolder, Krijbolder, D.I.
Observed institutions: Leiden University, Leiden University Medical Center, Erasmus MC, The Catholic University of Korea St. Vincent's Hospital, Reinier de Graaf Hospital, Maasstad Ziekenhuis, Groene Hart Ziekenhuis, Haga Hospital, Catholic University of Korea
ORCID: 0000-0003-1654-1031
Observed ORCID: 0000-0003-1654-1031
OpenAlex ID: A5070742246
Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial
2022 · Doortje I Krijbolder, Marloes Verstappen, et al. · The Lancet · 183
Temporal behaviour profiles of Mus musculus in nature are affected by population activity
2014 · Yuri Robbers, Eva A.S. Koster, et al. · Physiology & Behavior · 24
Development of rheumatoid arthritis after methotrexate in anticitrullinated protein antibody-negative people with clinically suspect arthralgia at risk of rheumatoid arthritis: 4-year data from the TREAT EARLIER trial
2024 · Quirine A Dumoulin, Doortje I Krijbolder, et al. · The Lancet Rheumatology · 21
Morning stiffness precedes the development of rheumatoid arthritis and associates with systemic and subclinical joint inflammation in arthralgia patients
2021 · Doortje I Krijbolder, Fenne Wouters, et al. · Lara D. Veeken · 20
PDF
Patient burden and joint inflammation during development of RA from arthralgia: is it similar in ACPA-positive and ACPA-negative disease?
2024 · Sarah J H Khidir, Doortje I Krijbolder, et al. · Lara D. Veeken · 16
PDF
Joint involvement in RA starts predominantly in the hands: functional, clinical and imaging studies in clinically suspect arthralgia and during progression to RA
2023 · Sarah J H Khidir, Bastiaan T van Dijk, et al. · RMD Open · 14
PDF
Hand function is already reduced before RA development and reflects subclinical tenosynovitis
2023 · Doortje Isabelle Krijbolder, Sarah J H Khidir, et al. · RMD Open · 12
PDF
A deep learning-based comparative MRI model to detect inflammatory changes in rheumatoid arthritis
2023 · Tahereh Hassanzadeh, Denis P. Shamonin, et al. · Biomedical Signal Processing and Control · 10
PDF
When does obesity exert its effect in conferring risk of developing RA: a large study in cohorts of symptomatic persons at risk
2024 · Quirine A Dumoulin, Anna M P Boeren, et al. · RMD Open · 9
PDF
The Natural Sequence in Which Subclinical Inflamed Joint Tissues Subside or Progress to Rheumatoid Arthritis: A Study of Serial MRIs in the TREAT EARLIER Trial
2023 · Doortje I. Krijbolder, Xanthe M. E. Matthijssen, et al. · Arthritis & Rheumatology · 9
PDF
Which inflamed tissues explain a positive metatarsophalangeal squeeze test? A large imaging study to clarify a common diagnostic procedure
2022 · Bastiaan T van Dijk, Yousra J Dakkak, et al. · Lara D. Veeken · 9
PDF
To treat or not to treat? Current attitudes on treatment aimed at modifying the disease burden in clinically suspect arthralgia: a survey among participants of the TREAT EARLIER trial and healthcare professionals
2023 · Doortje I Krijbolder, Sarah J H Khidir, et al. · RMD Open · 7
PDF
Correspondence on ‘Role of joint damage, malalignment and inflammation in articular tenderness in rheumatoid arthritis, psoriatic arthritis and osteoarthritis‘
2021 · Quirine A Dumoulin, Xanthe M E Matthijssen, et al. · Annals of the Rheumatic Diseases · 5
PDF
Op0324 Long-term Sustainability of Methotrexate Intervention in Anticitrullinated Protein Antibody-positive and Autoantibody-negative Arthralgia Patients at Increased Risk for Rheumatoid Arthritis on Disease Development and Disease Burden; 5 Year Results From the Treat Earlier Trial
2025 · Q.A. Dumoulin, H.W. van Steenbergen, et al. · Annals of the Rheumatic Diseases · 4
Pos0649 When Does Obesity Exert Its Effect in Conferring Risk of Developing Ra – a Large Study in Cohorts of Symptomatic Patients at Risk
2023 · Q. Dumoulin, D. Krijbolder, et al. · Annals of the Rheumatic Diseases · 2
PDF
Op0070 Intervention With Methotrexate in Arthralgia at Risk for Rheumatoid Arthritis to Reduce the Development of Persistent Arthritis and Its Disease Burden (treat Earlier): a Double-blind, Randomised, Placebo-controlled Trial
2022 · D. Krijbolder, M. Verstappen, et al. · Annals of the Rheumatic Diseases · 2
PDF
Pos0061 Interception of the Development of Rheumatoid Arthritis by a 1-year Course of Methotrexate in Acpa-negative Arthralgia Patients at Increased Risk for Rheumatoid Arthritis: 4 Year Results of the Treat Earlier Trial
2024 · Q.A. Dumoulin, D.I. Krijbolder, et al. · Annals of the Rheumatic Diseases · 1
Exploratory analysis of the TREAT EARLIER trial: is the efficacy of temporary methotrexate treatment dose-dependent?
2023 · Doortje I Krijbolder, Hido D Boom, et al. · The Lancet Rheumatology · 1
Grip strength reduction in clinically suspect arthralgia: natural trajectories and improvement after treatment
2023 · Doortje I Krijbolder, Fenne Wouters, et al. · RMD Open · 1
PDF
Pos1391 Measuring Subclinical Inflammation in Hand and Forefoot in Patients With Arthralgia Using 1.5t or 3.0t Mri: Does Field Strength Matter?
2021 · D. Krijbolder, M. Verstappen, et al. · Annals of the Rheumatic Diseases · 1
PDF
Long-term durability of a time-limited methotrexate intervention in patients with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative arthralgia at increased risk for rheumatoid arthritis (TREAT EARLIER): 5-year data from a double-blind, randomised, placebo-controlled trial
2026 · Elise van Mulligen, Quirine A Dumoulin, et al. · The Lancet Rheumatology
Op0261 the Natural Sequence in Which Subclinically Inflamed Joint Tissues Progress to Clinical Arthritis or Subside; a Study on Serial Mris in the Placebo-arm of the Treat Earlier Trial
2023 · D. Krijbolder, X. Matthijssen, et al. · Annals of the Rheumatic Diseases
PDF
Pos0319 the Course of Symptoms in Clinically Suspect Arthralgia and Its Relation With Subclinical Joint-inflammation During Progression to Ra: Is It Similar in Acpa-positive and Acpa-negative Disease?
2023 · S. Khidir, D. Krijbolder, et al. · Annals of the Rheumatic Diseases
PDF
Pos1082 Joint Involvement in Ra Starts Predominantly in the Hands: Functional, Clinical and Imaging Studies in Clinically Suspect Arthralgia and During Progression to Ra
2023 · S. Khidir, B. Van Dijk, et al.
PDF
Pos0976 Hand Function Is Already Reduced Before Ra-development and Reflects Subclinical Tenosynovitis
2023 · D. Krijbolder, S. Khidir, et al.
PDF
Works count: 29
Citation count: 351
H-index: 9
I10-index: 8
Year
Topic
Type